Top of the morning to you. A spot of rain is descending on the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say, “Every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and invite you to join us. Our choice today is mountain blueberry. Meanwhile, here are a few items of interest. Hope you have a smashing day, and, of course, do stay in touch. …
Workers at a plant in Baltimore manufacturing two Covid-19 vaccines accidentally conflated the ingredients several weeks ago, contaminating up to 15 million doses of Johnson & Johnson’s (JNJ) vaccine and forcing regulators to delay authorization of the plant’s production lines, The New York Times reports. The plant is run by Emergent BioSolutions (EBS), a manufacturing partner to both J&J and AstraZeneca (AZN), whose vaccine has yet to be authorized for use in the U.S. Federal officials attributed the mistake to human error.
About the Author Reprints
If memory serves (and it may not …), the BMS issue mentioned above raises echo’s of the so called “Synthes exception” in 2012 that J&J exercised successfully BUT the IRS later said would not be able to be exercised again. The timing of 9 years is instructive?